Creo Medical GroupCMEOF 53 Quick Ratio is 2.88 as of Dec. 2025, which is 1% below its 10-year median of 2.92. GuruFocus rates CMEOF with a GF Score™ of 53/100 and a GF Value™ of $0.25. The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Creo Medical Group ranks better than 66.78% on this metric.
Creo Medical Group has a quick ratio of 2.88. It generally indicates good short-term financial strength.
The historical rank and industry rank for Creo Medical Group's Quick Ratio or its related term are showing as below:
CMEOF'
s Quick Ratio Range Over the Past 10 Years
Min: 1.4 Med: 2.92 Max: 16.88
Current: 2.88
During the past 11 years, Creo Medical Group's highest Quick Ratio was 16.88. The lowest was 1.40. And the median was 2.92.
CMEOF's Quick Ratio is ranked better than 66.78% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.86
vs CMEOF: 2.88
Creo Medical Group (OTCPK:CMEOF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Creo Medical Group Quick Ratio Related Terms
Creo Medical Group Quick Ratio Historical Data
* Premium members only.
The historical data trend for Creo Medical Group's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Creo Medical Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creo Medical Group Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Creo Medical Group's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Creo Medical Group's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creo Medical Group (CMEOF) has a Quick Ratio of 2.88 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Creo Medical Group and its competitors. This is near median its historical median of 2.92. Over the past decade, Creo Medical Group's Quick Ratio has ranged from 1.40 to 16.88. According to the industry distribution chart, Creo Medical Group ranks #284 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 33.2%.
Is Creo Medical Group's Quick Ratio too high?
Creo Medical Group's current Quick Ratio of 2.88 is near median its 10-year median of 2.92. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 16.88. The Medical Devices & Instruments industry median Quick Ratio is 1.86. Creo Medical Group's value of 2.88 is 54.8% above this industry median. Based on the distribution chart, Creo Medical Group ranks #284 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Creo Medical Group has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Creo Medical Group ranks #284 out of 855 companies for Quick Ratio. This puts Creo Medical Group in the upper half of its industry. The industry median Quick Ratio is 1.86. Creo Medical Group's value of 2.88 is 54.8% above this benchmark. Historically, Creo Medical Group's own Quick Ratio has ranged from 1.40 to 16.88 over the past decade. While the company's 10-year median is 2.92 vs. the industry median of 1.86, Creo Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.86, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Creo Medical Group's current Quick Ratio of 2.88 is 54.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Creo Medical Group and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creo Medical Group's current Quick Ratio is 2.88, which is near median its own 10-year median of 2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Creo Medical Group (CMEOF) has a current Quick Ratio of 2.88. The stock's GF Value™ is $0.25, compared to a current price of $0.20 — trading 20% below its estimated fair value. The current Quick Ratio is 2.88, which is near median its 10-year median of 2.92 and 54.8% above the Medical Devices & Instruments industry median of 1.86. Creo Medical Group's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Creo Medical Group (CMEOF), the current Quick Ratio is 2.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creo Medical Group (CMEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued.
The current stock price of $0.20 is trading 20% below its estimated GF Value™ of $0.25.
Key valuation signals for CMEOF:
Quick Ratio: 2.88 (near median its 10-year median of 2.92)
GF Value™: $0.25 vs. price of $0.20 (20% below fair value)
Industry Position: 54.8% above the Medical Devices & Instruments median (#284 of 855)
No single metric tells the full story. See the CMEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
53GF Score
Get the complete analysis for CMEOF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMEOF has been successfully added to your 
